• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清对从大鼠肝细胞悬浮液和原代培养物获得的清除率预测的影响。

Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes.

作者信息

Blanchard Nadège, Richert Lysiane, Notter Brigitte, Delobel Frederic, David Pascale, Coassolo Philippe, Lavé Thierry

机构信息

Pharma Research Basel (70/131), F. Hoffmann-LaRoche Ltd., Pharmaceuticals Division, Grenzacherstrasse No. 124, CH 4070 Basel, Switzerland.

出版信息

Eur J Pharm Sci. 2004 Oct;23(2):189-99. doi: 10.1016/j.ejps.2004.07.007.

DOI:10.1016/j.ejps.2004.07.007
PMID:15451007
Abstract

The objective of the present study was to compare two configurations of the hepatocyte model namely suspensions (SH) and conventional primary cultures (CPC) for their ability to predict the hepatic clearance in vivo in the rat and, to investigate the impact of serum on the prediction accuracy. The metabolic competences of several cytochrome P450 isoenzymes were investigated both in CPC and SH in the presence or absence of serum. Under the same conditions, the in vitro intrinsic clearance of six test compounds metabolised by a variety of phase I and phase II enzymes (antipyrine, RO-X, mibefradil, midazolam, naloxone and oxazepam) were derived from Vmax/Km scaled up to the corresponding in vivo hepatic metabolic clearance. CYP activities were shown to be stable in both CPC and SH for up to 6 h of incubation, except for the CYP 3A1 activity that decreased in CPC even in the presence of serum. Moreover, the clearances predicted from SH in the presence of serum were closer to the in vivo values than those obtained from CPC. SH represent a convenient model to assess the hepatic metabolism of xenobiotics, the presence of serum in the incubation medium significantly improved in several instances the quality of the predictions.

摘要

本研究的目的是比较肝细胞模型的两种配置,即悬浮液(SH)和传统原代培养物(CPC)预测大鼠体内肝脏清除率的能力,并研究血清对预测准确性的影响。在有或无血清存在的情况下,研究了CPC和SH中几种细胞色素P450同工酶的代谢能力。在相同条件下,由多种I相和II相酶(安替比林、RO-X、米贝拉地尔、咪达唑仑、纳洛酮和奥沙西泮)代谢的六种受试化合物的体外内在清除率由Vmax/Km推导得出,并按比例放大至相应的体内肝脏代谢清除率。结果显示,在长达6小时的孵育过程中,CPC和SH中的CYP活性均保持稳定,但CPC中的CYP 3A1活性即使在有血清存在的情况下也会下降。此外,血清存在时SH预测的清除率比CPC得到的清除率更接近体内值。SH是评估外源化合物肝脏代谢的便捷模型,孵育培养基中血清的存在在多个实例中显著提高了预测质量。

相似文献

1
Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes.血清对从大鼠肝细胞悬浮液和原代培养物获得的清除率预测的影响。
Eur J Pharm Sci. 2004 Oct;23(2):189-99. doi: 10.1016/j.ejps.2004.07.007.
2
A convenient in vitro screening method for predicting in vivo drug metabolic clearance using isolated hepatocytes suspended in serum.一种使用悬浮于血清中的分离肝细胞预测体内药物代谢清除率的便捷体外筛选方法。
Drug Metab Dispos. 2000 Dec;28(12):1518-23.
3
Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations.使用冷冻保存的人肝细胞预测肝清除率:血清孵育和无血清孵育的比较。
J Pharm Pharmacol. 2006 May;58(5):633-41. doi: 10.1211/jpp.58.5.0008.
4
Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures.从肝细胞预测体外固有清除率:悬浮液与单层培养物的比较
Drug Metab Dispos. 2005 Jan;33(1):115-20. doi: 10.1124/dmd.33.1..
5
Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations.用于确定体外代谢清除率的底物消耗法:肝细胞和微粒体孵育中的时间依赖性
Drug Metab Dispos. 2004 Sep;32(9):973-82. doi: 10.1124/dmd.104.000125.
6
Prediction of in vivo rat biliary drug clearance from an in vitro hepatocyte efflux model.从体外肝细胞流出模型预测体内大鼠胆汁药物清除率。
Drug Metab Dispos. 2014 Mar;42(3):459-68. doi: 10.1124/dmd.113.054155. Epub 2014 Jan 6.
7
Xenobiotic intrinsic clearance in freshly isolated hepatocytes from rainbow trout (Oncorhynchus mykiss): determination of trout hepatocellularity, optimization of cell concentrations and comparison of serum and serum-free incubations.虹鳟(Oncorhynchus mykiss)新鲜分离肝细胞中外源物质固有清除率:虹鳟肝细胞数量的测定、细胞浓度的优化以及血清和无血清孵育的比较。
Aquat Toxicol. 2008 Aug 11;89(1):11-7. doi: 10.1016/j.aquatox.2008.05.010. Epub 2008 May 23.
8
A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microsomes.一种基于肝细胞和微粒体体外内在清除率数据预测人体肝脏代谢清除率的统一模型。
Drug Metab Dispos. 2005 Sep;33(9):1304-11. doi: 10.1124/dmd.105.004259. Epub 2005 Jun 2.
9
The pivotal role of hepatocytes in drug discovery.肝细胞在药物发现中的关键作用。
Chem Biol Interact. 2007 May 20;168(1):2-15. doi: 10.1016/j.cbi.2006.11.002. Epub 2006 Nov 18.
10
Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.血浆蛋白结合对用三明治培养大鼠肝细胞评估的药物胆汁排泄体外-体内相关性的影响。
Drug Metab Dispos. 2008 Jul;36(7):1275-82. doi: 10.1124/dmd.107.019026. Epub 2008 Apr 3.

引用本文的文献

1
Hepatocellular Metabolic Profile: Understanding Post-Thawing Metabolic Shift in Primary Hepatocytes In Vitro.肝细胞代谢谱:了解原代肝细胞体外解冻后的代谢转变
Cells. 2025 May 29;14(11):803. doi: 10.3390/cells14110803.
2
Does Addition of Protein to Hepatocyte or Microsomal In Vitro Incubations Provide a Useful Improvement in In Vitro-In Vivo Extrapolation Predictability?在肝细胞或微粒体体外孵育中添加蛋白质是否能提供有用的改善体外-体内外推预测性?
Drug Metab Dispos. 2022 Apr;50(4):401-412. doi: 10.1124/dmd.121.000677. Epub 2022 Jan 27.
3
Recent developments in and models for improved translation of preclinical pharmacokinetics and pharmacodynamics data.
临床前药代动力学和药效学数据转化的 和 模型的最新进展。
Drug Metab Rev. 2021 May;53(2):207-233. doi: 10.1080/03602532.2021.1922435. Epub 2021 May 25.
4
The Presence of a Transporter-Induced Protein Binding Shift: A New Explanation for Protein-Facilitated Uptake and Improvement for In Vitro-In Vivo Extrapolation.存在转运蛋白诱导的蛋白结合位移:一种新的解释蛋白促进摄取和改善体外-体内外推。
Drug Metab Dispos. 2019 Apr;47(4):358-363. doi: 10.1124/dmd.118.085779. Epub 2019 Jan 23.
5
An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation.探讨与体外-体内外推相关的蛋白结合和蛋白促进摄取。
Eur J Pharm Sci. 2018 Oct 15;123:502-514. doi: 10.1016/j.ejps.2018.08.008. Epub 2018 Aug 8.
6
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.近年来,利用原代肝细胞、替代的肝细胞来源和非实质细胞的 2D 和 3D 体外系统在研究肝毒性、细胞信号转导和 ADME 的机制方面取得了进展。
Arch Toxicol. 2013 Aug;87(8):1315-530. doi: 10.1007/s00204-013-1078-5. Epub 2013 Aug 23.
7
Inhibitive effect of cremophor RH40 or tween 80-based self-microemulsiflying drug delivery system on cytochrome P450 3A enzymes in murine hepatocytes.聚氧乙烯蓖麻油RH40或吐温80基自微乳化给药系统对小鼠肝细胞中细胞色素P450 3A酶的抑制作用。
J Huazhong Univ Sci Technolog Med Sci. 2010 Oct;30(5):562-8. doi: 10.1007/s11596-010-0543-0. Epub 2010 Nov 10.
8
Design and application of microfluidic systems for in vitro pharmacokinetic evaluation of drug candidates.微流控系统的设计与应用:用于候选药物体外药代动力学评估。
Curr Drug Metab. 2009 Dec;10(10):1192-9. doi: 10.2174/138920009790820093.
9
Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.基于体外摄取转运数据预测缬沙坦在人体内的药代动力学特征。
J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):585-611. doi: 10.1007/s10928-009-9139-3. Epub 2009 Nov 20.
10
Prediction of hepatic clearance in human from in vitro data for successful drug development.从体外数据预测人体肝脏清除率以实现成功的药物开发。
AAPS J. 2009 Jun;11(2):262-76. doi: 10.1208/s12248-009-9103-6. Epub 2009 Apr 30.